Stuart M. Olley
Stuart M. Olley
Partner at Gowling WLG
(403) 298-1814
(403) 695-3486
421 7th Ave SW, Suite 1600, Calgary, AB
Year called to bar: 1993 (AB)
Stuart M. Olley is a senior partner in Gowling WLG's Capital Markets, M&A, and Private Equity groups in Calgary. He focuses on capital market transactions for both public and private enterprises, mergers & acquisitions, corporate governance, and private equity. Stuart has worked for a number of issuers and underwriters on transactions in various industries including oil & gas, mining, real estate, and technology. He has extensive experience in international financing and merger transactions, including work in investments and acquisitions in Africa, Central and South America, and Asia. Domestically, Stuart has assisted clients in the extractive sector with financings, business combinations (including contested proxy fights, hostile and friendly takeover bids, and restructuring transactions under the CCAA and the ABCA), corporate governance, and regulatory compliance. He is a past member of the Securities Advisory Council of the Alberta Securities Commission. Stuart has been recognized in The Canadian Legal Lexpert® Directory, The Best Lawyers in Canada, and The Legal 500 Canada. In 2018, 2019, and 2020 he was named an Acritas Star and, in 2020, he was recognized by Best Lawyers in Canada as Lawyer of the Year for Mining Law – Calgary.
Stuart M. Olley is a featured Leading Lawyer in:
Canadian Legal Lexpert Directory
Consistently Recommended
Read more about Stuart M. Olley in ...
Capital-intensive mining projects and long-term agreements in the industry, particularly outside of Canada, can be subject to political risk and change that can affect investment. How can investments best be protected?
Petroamerica Oil Corp. and Suroco Energy Inc. fended off a hostile bid by Vetra Holding S.a.r.l. and Vetra Acquisition Ltd. and completed a plan of arrangement pursuant to which Petroamerica acquired all the issued and outstanding shares of Suroco for an approximate total value of $108.6 million.
On July 13, 2001, KS Biomedix Plc of the United Kingdom completed the purchase of all of the outstanding shares of Avicenna Medica Inc. of Edmonton, Alberta for a total purchase price of $90 million.